GSK (NYSE:GSK) is pursuing a focused oncology expansion built around hematologic malignancies, gynecologic cancers, lung ...

GSK is consolidating two of its influenza vaccine manufacturing sites into one, leaving hundreds of jobs at risk.  | GSK is ...

GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at ...

Haleon's dual-placement strategy for Advil and TUMS at CVS lifted first-quarter sales per store, and talks with Walmart are ...

GSK stock rose 0.4% after Berenberg upgraded to buy with a £22 target and GSK announced a $750M deal with Chimagen Biosciences for a multiple myeloma asset.

GSK's Specialty Medicines are driving growth, but an approaching HIV patent cliff is pushing the company to accelerate its ...

GSK said its Jideytro drug showed benefits for patients with a type of lung cancer in a clinical trial, a finding that could help the company seek approval for the medicine at an earlier stage of ...

GSK (LSE:GSK) was upgraded to “buy” from “hold” by Berenberg, with the broker raising its price target to £22 from £20 following an assessment of the drugmaker’s pipeline and recent ...

Analysts at Berenberg upgraded drugmaker GSK from 'hold' to 'buy' on Tuesday and lifted their target price on the stock from ...

UK pharma major GSK today announced it has entered an agreement to acquire a potential best-in-class trispecific T ...

UK pharma major GSK (LSE: GSK) has set out full survival data for risvutatug rezetecan, its B7-H3 targeted antibody-drug ...

Brokerages expect strong near-term growth on traction in innovative products and new launches, though some see limited upside after the stock's recent outperformance ...